Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Strong Cash Position and Clinical ... [Yahoo! Finance]
Mind Medicine (MindMed) Inc. - Common Shares (MNMD)
Company Research
Source: Yahoo! Finance
Research and Development Expenses: $17.2 million for the quarter ended September 30, 2024, up from $13.2 million for the same period in 2023. General and Administrative Expenses: $7.6 million for the quarter ended September 30, 2024, down from $8.4 million for the same period in 2023. Net Loss: $13.7 million for the quarter ended September 30, 2024, compared to $17.9 million for the same period in 2023. Warning! GuruFocus has detected 1 Warning Sign with MNMD. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Mind Medicine Inc ( NASDAQ:MNMD ) is on track to initiate multiple phase three studies for its MM 120 ODT in generalized anxiety disorder (GAD) and major depressive disorder (MDD), indicating strong progress in its clinical development pipeline. The company has a robust cash position with $295.3 million in cash and cash equivalents, which is expected to fund operations into 2027, prov
Show less
Read more
Impact Snapshot
Event Time:
MNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNMD alerts
High impacting Mind Medicine (MindMed) Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MNMD
News
- MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceBusiness Wire
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.MarketBeat
- MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety DisorderBusiness Wire
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $23.00 price target on the stock.MarketBeat
- Why Mind Medicine Stock Is Soaring Today [Yahoo! Finance]Yahoo! Finance
MNMD
Earnings
- 11/7/24 - Beat
MNMD
Sec Filings
- 2/5/25 - Form SCHEDULE
- 1/30/25 - Form 8-K
- 1/13/25 - Form 8-K
- MNMD's page on the SEC website